Amedeo Smart

Free Medical Literature Service



Chronic Renal Failure

  Free Subscription

Articles published in
Osteoporos Int
    April 2018
  1. THONGPRAYOON C, Acharya P, Acharya C, Chenbhanich J, et al
    Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.
    Osteoporos Int. 2018 Apr 30. pii: 10.1007/s00198-018-4533.
    >> Share

    March 2018
  2. ALEKSOVA J, Kurniawan S, Elder GJ
    The trabecular bone score is associated with bone mineral density, markers of bone turnover and prevalent fracture in patients with end stage kidney disease.
    Osteoporos Int. 2018 Mar 19. pii: 10.1007/s00198-018-4468.
    >> Share

    February 2018
  3. PRZEDLACKI J, Buczynska-Chyl J, Kozminski P, Niemczyk E, et al
    The utility of FRAX(R) in predicting bone fractures in patients with chronic kidney disease on hemodialysis: a two-year prospective multicenter cohort study.
    Osteoporos Int. 2018 Feb 6. pii: 10.1007/s00198-018-4406.
    >> Share

    May 2017
  4. PEREZ-SAEZ MJ, Herrera S, Prieto-Alhambra D, Vilaplana L, et al
    Bone density, microarchitecture, and material strength in chronic kidney disease patients at the time of kidney transplantation.
    Osteoporos Int. 2017 May 11. doi: 10.1007/s00198-017-4065.
    >> Share

    February 2017
  5. MARQUES ID, Araujo MJ, Graciolli FG, Reis LM, et al
    Biopsy vs. peripheral computed tomography to assess bone disease in CKD patients on dialysis: differences and similarities.
    Osteoporos Int. 2017 Feb 16. doi: 10.1007/s00198-017-3956.
    >> Share

    December 2016
  6. FAHRLEITNER-PAMMER A, Wagner D, Krisper P, Amrein K, et al
    Teriparatide treatment in a heart transplant patient with a chronic kidney disease and a low-turnover bone disease: a case report.
    Osteoporos Int. 2016.
    >> Share

  7. OTA M, Takahata M, Shimizu T, Kanehira Y, et al
    Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Osteoporos Int. 2016.
    >> Share

    September 2016
  8. ATTERITANO M, Di Mauro E, Canale V, Bruzzese AM, et al
    Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.
    Osteoporos Int. 2016.
    >> Share

    July 2016
  9. CHANG AJ, Ying Q, Chen XN, Wang WM, et al
    Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis.
    Osteoporos Int. 2016.
    >> Share

    May 2016
  10. LEE SA, Lee MJ, Ryu GW, Jhee JH, et al
    Low serum intact parathyroid hormone level is an independent risk factor for overall mortality and major adverse cardiac and cerebrovascular events in incident dialysis patients.
    Osteoporos Int. 2016.
    >> Share

    February 2016
  11. VIAENE L, Behets GJ, Heye S, Claes K, et al
    Inflammation and the bone-vascular axis in end-stage renal disease.
    Osteoporos Int. 2016;27:489-97.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016